216 related articles for article (PubMed ID: 35474600)
1. Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
van Riel LAMJG; Geboers B; Kabaktepe E; Blazevski A; Reesink DJ; Stijns P; Stricker PD; Casanova J; Dominguez-Escrig JL; de Reijke TM; Scheltema MJ; Oddens JR
BJU Int; 2022 Nov; 130(5):611-618. PubMed ID: 35474600
[TBL] [Abstract][Full Text] [Related]
2. Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.
Blazevski A; Gondoputro W; Scheltema MJ; Amin A; Geboers B; Barreto D; Haynes AM; Shnier R; Delprado W; Agrawal S; Thompson JE; Stricker PD
BMC Urol; 2022 Mar; 22(1):28. PubMed ID: 35236338
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
BJU Int; 2017 Nov; 120 Suppl 3():51-58. PubMed ID: 28834167
[TBL] [Abstract][Full Text] [Related]
4. [Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].
Vidmar R; Marcq G; Flamand V; Fantoni JC; Hénon F; Villers A; Ouzzane A
Prog Urol; 2017; 27(8-9):458-466. PubMed ID: 28576424
[TBL] [Abstract][Full Text] [Related]
5. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
6. Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial.
Blazevski A; Geboers B; Scheltema MJ; Gondoputro W; Doan P; Katelaris A; Agrawal S; Baretto D; Matthews J; Haynes AM; Delprado W; Shnier R; van den Bos W; Thompson JE; Lawrentschuk N; Stricker PD
BJU Int; 2023 Jun; 131 Suppl 4():23-31. PubMed ID: 36495482
[TBL] [Abstract][Full Text] [Related]
7. Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.
Geboers B; Scheltema MJ; Blazevski A; Katelaris A; Doan P; Ali I; Agrawal S; Barreto D; Matthews J; Haynes AM; Delprado W; Shnier R; Thompson JE; Stricker PD
BJU Int; 2023 Jun; 131 Suppl 4():14-22. PubMed ID: 36594205
[TBL] [Abstract][Full Text] [Related]
8. Salvage radical prostatectomy following focal therapy: functional and oncological outcomes.
Herrera-Caceres JO; Nason GJ; Salgado-Sanmamed N; Goldberg H; Woon DTS; Chandrasekar T; Ajib K; Tan GH; Alhunaidi O; van der Kwast T; Finelli A; Zlotta AR; Hamilton RJ; Berlin A; Perlis N; Fleshner NE
BJU Int; 2020 Apr; 125(4):525-530. PubMed ID: 31863617
[TBL] [Abstract][Full Text] [Related]
9. Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.
Scheltema MJ; Geboers B; Blazevski A; Doan P; Katelaris A; Agrawal S; Barreto D; Shnier R; Delprado W; Thompson JE; Stricker PD
BJU Int; 2023 Jun; 131 Suppl 4():6-13. PubMed ID: 36495481
[TBL] [Abstract][Full Text] [Related]
10. Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications.
Rosoff JS; Savage SJ; Prasad SM
World J Urol; 2013 Dec; 31(6):1347-52. PubMed ID: 23358790
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electroporation) for Localised Prostate Cancer.
Nathan A; Ng A; Mitra A; Sooriakumaran P; Davda R; Patel S; Fricker M; Kelly J; Shaw G; Rajan P; Sridhar A; Nathan S; Payne H
Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e69-e78. PubMed ID: 34740477
[TBL] [Abstract][Full Text] [Related]
12. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
[TBL] [Abstract][Full Text] [Related]
13. Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.
Qaoud Y; Herrera-Caceres JO; Bass R; Berjaoui MB; Tiwari R; Kenk M; Lajkosz K; Finelli A; Perlis N; Klotz L; Fleshner N
Urol Oncol; 2022 Jul; 40(7):343.e1-343.e6. PubMed ID: 35537905
[TBL] [Abstract][Full Text] [Related]
14. Techniques and Outcomes of Salvage Robot-Assisted Radical Prostatectomy (sRARP).
De Groote R; Nathan A; De Bleser E; Pavan N; Sridhar A; Kelly J; Sooriakumaran P; Briggs T; Nathan S
Eur Urol; 2020 Dec; 78(6):885-892. PubMed ID: 32461073
[TBL] [Abstract][Full Text] [Related]
15. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy.
Scheltema MJ; Chang JI; Böhm M; van den Bos W; Blazevski A; Gielchinsky I; Kalsbeek AMF; van Leeuwen PJ; Nguyen TV; de Reijke TM; Siriwardana AR; Thompson JE; de la Rosette JJ; Stricker PD
World J Urol; 2018 Sep; 36(9):1383-1389. PubMed ID: 29594551
[TBL] [Abstract][Full Text] [Related]
16. Critical analysis of salvage radical prostatectomy in the management of radioresistant prostate cancer.
Seabra D; Faria E; Dauster B; Rodrigues G; Fava G
Int Braz J Urol; 2009; 35(1):43-8. PubMed ID: 19254397
[TBL] [Abstract][Full Text] [Related]
17. Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria.
Mandel P; Steuber T; Ahyai S; Kriegmair M; Schiffmann J; Boehm K; Heinzer H; Michl U; Schlomm T; Haese A; Huland H; Graefen M; Tilki D
BJU Int; 2016 Jan; 117(1):55-61. PubMed ID: 25711672
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
Clery R; Grande P; Seisen T; Gobert A; Duquesne I; Villers A; Olivier J; Bernhard JC; Robert G; Beauval JB; Prudhomme T; Bruyère F; Lainé-Caroff P; Waltregny D; Guillonneau B; Panarello D; Ruffion A; De Bayser H; de La Taille A; Roupret M
World J Urol; 2019 Aug; 37(8):1491-1498. PubMed ID: 30790014
[TBL] [Abstract][Full Text] [Related]
19. Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer.
Preisser F; Würnschimmel C; Pose RM; Heinze A; Steuber T; Michl U; Salomon G; Mandel P; Graefen M; Tilki D
Prostate; 2022 Feb; 82(2):254-259. PubMed ID: 34807461
[TBL] [Abstract][Full Text] [Related]
20. Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?
Ribeiro L; Stonier T; Stroman L; Tourinho-Barbosa R; Alghazo O; Winkler M; Dasgupta P; Popert R; Cathelineau X; Sanchez-Salas R; Murphy DG; Emberton M; Cathcart P
J Urol; 2021 Mar; 205(3):791-799. PubMed ID: 33021441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
